Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma

Lenalidomide is an agent that has shown great activity in patients with multiple myeloma. However, studies have suggested that this drug negatively affects subsequent stem cell collection. To investigate whether lenalidomide impairs stem cell mobilization and collection, we reviewed data for patient...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Popat, Uday, Saliba, Rima, Thandi, Rupinderjit, Hosing, Chitra, Qazilbash, Muzaffar, Anderlini, Paolo, Shpall, Elizabeth, McMannis, John, Körbling, Martin, Alousi, Amin, Andersson, Borje, Nieto, Yago, Kebriaei, Partow, Khouri, Issa, de Lima, Marcos, Weber, Donna, Thomas, Sheeba, Wang, Michael, Jones, Roy, Champlin, Richard, Giralt, Sergio
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352933/
https://ncbi.nlm.nih.gov/pubmed/19450756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.02.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items